Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part ...

Indianapolis-based Eli Lilly has tapped Lucas Montarce as its new executive vice president and CFO, effective immediately. Mr. Montarce was also named a member of Eli Lilly's executive committee ...

Eli Lilly stirred up confusion this week when its CFO, Lucas Montarce, made statements suggesting that its telehealth partners do not compound tirzepatide or semaglutide—active ingredients in popular ...

INDIANAPOLIS, May 2, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Bank of America Securities 2025 Healthcare Conference, May 15, 2025. Lucas Montarce, Lilly ...

The results come days after Pfizer, which once angled for second place, was forced to abandon its most advanced weight-loss pill over safety concerns. Pfizer will likely have to acquire a smaller ...

Trial data data showed Lilly's experimental weight-loss pill worked as well as the Ozempic shot, bringing it one step closer to developing a needle-free alternative to injections.

Eli Lilly aims to expand its global footprint by introducing its blockbuster drug, Mounjaro, to major markets such as China, India, Brazil, and Mexico by 2026, according to Chief Financial Officer ...

(Reuters) -Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro, in countries like China, India, Brazil and Mexico by 2026, Chief Financial Officer Lucas Montarce said on ...

INDIANAPOLIS, Feb. 28, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in Leerink Partners Global Healthcare Conference on March 10, 2025. Lucas Montarce, Lilly executive vice ...

Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soared. The company's quarterly earnings ...